Cigna Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $406K | Sell |
1,245
-52
| -4% | -$17K | 0.07% | 273 |
|
|
2025
Q1 | $351K | Hold |
1,297
| – | – | 0.07% | 290 |
|
|
2024
Q4 | $305K | Hold |
1,297
| – | – | 0.05% | 343 |
|
|
2024
Q3 | $357K | Sell |
1,297
-25
| -2% | -$6.88K | 0.06% | 309 |
|
|
2024
Q2 | $321K | Sell |
1,322
-30
| -2% | -$7.28K | 0.06% | 313 |
|
|
2024
Q1 | $202K | Buy |
1,352
+30
| +2% | +$4.48K | 0.04% | 441 |
|
|
2023
Q4 | $253K | Hold |
1,322
| – | – | 0.05% | 361 |
|
|
2023
Q3 | $235K | Hold |
1,322
| – | – | 0.05% | 364 |
|
|
2023
Q2 | $251K | Hold |
1,322
| – | – | 0.05% | 384 |
|
|
2023
Q1 | $265K | Sell |
1,322
-36
| -3% | -$7.22K | 0.05% | 363 |
|
|
2022
Q4 | $323K | Buy |
1,358
+23
| +2% | +$5.47K | 0.07% | 319 |
|
|
2022
Q3 | $267K | Buy |
+1,335
| New | +$267K | 0.06% | 335 |
|
|
2022
Q2 | – | Sell |
-1,270
| Closed | -$207K | – | 460 |
|
|
2022
Q1 | $207K | Buy |
+1,270
| New | +$207K | 0.03% | 567 |
|